alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › longitudinal-tau

longitudinal-tau

3 studies tagged longitudinal-tau, dated 2002-11-01 to 2023-09-25. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. APOEε4 potentiates amyloid β effects on longitudinal tau pathology 2023-09-25
  2. CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design 2022-02-28
  3. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment 2002-11-01

Studies

3 studies carry this tag.

Date range

2002 to 2023

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Nature aging 1
  • Neuroscience letters 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. APOEε4 potentiates amyloid β effects on longitudinal tau pathology

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Nature aging 2023-09-25 Biomarkers

    The mechanisms by which the apolipoprotein E ε4 (APOEε4) allele influences the pathophysiological progression of Alzheimer's disease (AD) are poorly understood.

  2. CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-02-28 Biomarkers

    Clinical trials testing tau-targeting therapies may benefit from using fluid biomarkers to recruit individuals at risk of tau aggregation.

  3. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neuroscience letters 2002-11-01 Biomarkers

    Cross-sectional cerebrospinal fluid (CSF) levels of tau and amyloid (A) beta (beta) are of diagnostic importance for Alzheimer's disease (AD) and mild cognitive impairment (MCI).

All topic tags with their study counts